Last updated on 23-8-2019 by Anonymous (niet gecontroleerd)
Public Access
Published
Auteurs
M. Taha; Hedberg,S.T.; Szatanik,M.; Hong,E.; Ruckly,C.; Abad,R.; Sophie Bertrand; Carion,F.; Claus,H.; Corso,A.; Enriquez,R.; Heuberger,S.; Hryniewicz,W.; Jolley,K.A.; Kriz,P.; Mollerach,M.; Musilek,M.; Neri,A.; Olcen,P.; Pana,M.; Skoczynska,A.; P.C. Sorhouet; Stefanelli,P.; Tzanakaki,G.; Unemo,M.; Vazquez,J.A.; Vogel,U.; Wasko,I.Trefwoorden
Samenvatting:
Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number (n = 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of > or = 0.25 mg/liter (n = 161) received by the national reference la…